Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant vs Interval Mifepristone and Misoprostol for Medical Abortion
NCT03440866Unknown
- Sponsor
- Emek Medical Center
- Start
- Mar 2018
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of mifepristone and misoprostol (2 arms), sponsored by Emek Medical Center. Primary endpoint: Success rate of complete abortion at 2 weeks. Status: unknown.
02
Drugs
mifepristonemisoprostol
Beyond the preview
Go deeper on NCT03440866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03440866.